FDA

Syringes
Feature Article
|

Pharmapack Europe covered lots of ground

Exclusive coverage fom Pharmapack Europe includes strategies for handling injectables, updates on new regs for med devices, and a look at the challenges of veterinary drugs.
E-Book Special Report
Total Cost of Ownership
Sign up to receive timely updates from our editors and download this E-Book Special Report to learn how to calculate the true Total Cost of Ownership (TCO) of your packaging machinery.
News
|

FDA issues guidance for repackaging

The U.S. Food and Drug Administration issued a Feb. 2015 Guidance for Industry titled, “Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities,” that is being distributed for comment purposes only.
Eric Greenberg
Column/Opinion
|

Regulators have a range of approaches

What is the best way for a state to assure that people drive safely?
Afrezza (insulin human) Inhalation Powder
Package Case Study
|

Sanofi launches Afrezza inhalable insulin for diabetes treatment

Global healthcare company Sanofi and biopharma-ceutical company MannKind Corp. announced that Afrezza (insulin human) Inhalation Powder is now available by prescription in U.S. retail pharmacies nationwide.
Global Data forecast sees significant U.S. pharmaceutical market growth
News
|

Forecast sees significant U.S. pharmaceutical market growth

The Patient Protection and Affordable Care Act, faster FDA product approvals, and millions of previously uninsured people potentially entering the patient pool expected to help drive future pharmaceutical growth.
Eric Greenberg
Column/Opinion
|

Sunscreens: follow FDA specs or get burned

You know what’s great about modern healthcare?
Drug compounding
News
|

FDA issues guidance for outsourcing facilities

On Nov. 21, 2014, the U.S. Food and Drug Administration issued three additional policy documents to assist entities that compound sterile human drugs with registering as outsourcing facilities.
Kevin O'Donnell is Vice President, Cold Chain Standards, Practices & Compliance at BioLife Solutions, Inc., and is a Contributin
Column/Opinion
|

Test your cold chain IQ

True or false questions about the handling of biologics and drugs in the supply chain.
Dirk Rodgers is a Contributing Editor for Healthcare Packaging and author of RxTrace.
Column/Opinion
|

DSCSA answers are needed

FDA is not addressing the questions people are asking.
Eric F. Greenberg is a Contributing Editor and Legal & Regulatory columnist for Packaging World and Healthcare Packaging.
Column/Opinion
|

What is considered a drug?

FDA Warning Letters provide reminder of the basics of drug regulation.

Pages

Subscribe to FDA

Newsletters

Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
GENERAL INTEREST
PACKAGE DESIGN/DEVELOPMENT
PACKAGING MACHINERY
SPECIAL INTEREST
PACK EXPO
Each newsletter ranges in frequency from once per month to a few times per month at most.